Toby Winton‐Brown
Impact in
- Pharmacology top 1%
- Cannabis and Cannabinoid Research
- Biological Psychiatry top 5%
Papers in
-
- Psychosomatic Disorders and Their Treatments 10
- Epilepsy research and treatment 9
- Schizophrenia research and treatment 9
- Co-authors
- Philip McGuire (16 shared papers)Paolo Fusar‐Poli (6 shared papers)Oliver Howes (8 shared papers)Paul Allen (10 shared papers)Sagnik Bhattacharyya (6 shared papers)Mark A. Ungless (1 shared paper)Rocío Martín‐Santos (3 shared papers)Andrea Mechelli (1 shared paper)
- Journals
- Epilepsy & Behavior (9 papers)Schizophrenia Research (6 papers)Epilepsia (3 papers)BMJ Open (2 papers)Neuropsychopharmacology (2 papers)
- Partner nations
- AustraliaUnited KingdomUnited States
In The Last Decade
Toby Winton‐Brown
41 papers receiving 2.1k citations
Toby Winton‐Brown's Hit Papers
Peers
Comparison fields: 5 of 114
- Pharmacology 679
- Biological Psychiatry 96
- Psychiatry and Mental health 543
- Cognitive Neuroscience 647
- Cellular and Molecular Neuroscience 448
Countries citing papers authored by Toby Winton‐Brown
This map shows the geographic impact of Toby Winton‐Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toby Winton‐Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toby Winton‐Brown more than expected).
Fields of papers citing papers by Toby Winton‐Brown
This network shows the impact of papers produced by Toby Winton‐Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toby Winton‐Brown. The network helps show where Toby Winton‐Brown may publish in the future.
Co-authors
The 25 scholars most cited alongside Toby Winton‐Brown, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology Hit paper breakdown → | 2009 | 543 |
| 2 | 2013 | 340 | |
| 3 | 2013 | 184 | |
| 4 | 2014 | 183 | |
| 5 | 2020 | 140 | |
| 6 | 2011 | 112 | |
| 7 | 2020 | 92 | |
| 8 | 2016 | 77 | |
| 9 | 2012 | 57 | |
| 10 | 2016 | 46 | |
| 11 | 2017 | 44 | |
| 12 | 2009 | 43 | |
| 13 | 2016 | 37 | |
| 14 | 2009 | 28 | |
| 15 | 2021 | 26 | |
| 16 | 2022 | 19 | |
| 17 | 2015 | 17 | |
| 18 | 2021 | 16 | |
| 19 | 2014 | 13 | |
| 20 | 2022 | 12 |
About Toby Winton‐Brown
Toby Winton‐Brown is a scholar working on Psychiatry and Mental health, Clinical Psychology, Cellular and Molecular Neuroscience, Cognitive Neuroscience and Pharmacology, having authored 46 papers that have together received 2.1k indexed citations. Recurring topics across this work include Psychosomatic Disorders and Their Treatments (10 papers), Epilepsy research and treatment (9 papers), Schizophrenia research and treatment (9 papers), Neuroscience and Neuropharmacology Research (4 papers), Cannabis and Cannabinoid Research (4 papers), Neurotransmitter Receptor Influence on Behavior (4 papers), Functional Brain Connectivity Studies (4 papers) and Neurology and Historical Studies (2 papers). The work is most often cited by research in Pharmacology (679 citations), Biological Psychiatry (96 citations), Psychiatry and Mental health (543 citations), Cognitive Neuroscience (647 citations) and Cellular and Molecular Neuroscience (448 citations). Toby Winton‐Brown has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include Philip McGuire, Paolo Fusar‐Poli, Oliver Howes, Paul Allen, Sagnik Bhattacharyya, Mark A. Ungless, Rocío Martín‐Santos, Andrea Mechelli, Nicolás Crossley and Ameera X. Patel. Their work appears in journals such as Epilepsy & Behavior, Schizophrenia Research, Epilepsia, BMJ Open and Neuropsychopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.